Neurology
2 drugs are in development for Prader-Willi Syndrome.
- Companies
- 2
- Clinical trials
- 12
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Prader-Willi Syndrome pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| vykat xr | SOLENO THERAPEUTICS INC (SLNO) |
Phase 3(1)
| Drug | Company |
|---|---|
| ARD-101 | Aardvark Therapeutics, Inc. (AARD) |
About this indication
Prader-Willi Syndrome context
Neurology·MeSH: Prader-Willi Syndrome (D011218)
Also known as: Labhart Willi Prader Fanconi Syndrome, Labhart Willi Syndrome, Syndrome, Prader-Labhart-Willi, Syndrome, Willi-Prader
Frequently asked questions
How many drugs are in development for Prader-Willi Syndrome?
BioSniper tracks 2 drugs in development for Prader-Willi Syndrome across 2 companies.
How many clinical trials target Prader-Willi Syndrome?
There are 12 clinical trials targeting Prader-Willi Syndrome tracked by BioSniper.